Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
5,660.00
+60.00 (1.07%)
At close: Aug 7, 2025, 3:30 PM KST
Aspen Technology Revenue
Sinsin Pharmaceutical had revenue of 25.31B KRW in the quarter ending March 31, 2025, with 2.43% growth. This brings the company's revenue in the last twelve months to 106.99B, up 3.05% year-over-year. In the year 2024, Sinsin Pharmaceutical had annual revenue of 106.39B with 3.71% growth.
Revenue (ttm)
106.99B
Revenue Growth
+3.05%
P/S Ratio
0.80
Revenue / Employee
304.81M
Employees
351
Market Cap
85.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 106.39B | 3.80B | 3.71% |
Dec 31, 2023 | 102.59B | 10.66B | 11.60% |
Dec 31, 2022 | 91.93B | 17.92B | 24.21% |
Dec 31, 2021 | 74.01B | 6.88B | 10.25% |
Dec 31, 2020 | 67.13B | -725.72M | -1.07% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
Doosan Enerbility | 15.88T |
HD Hyundai Heavy Industries | 15.32T |